Carbatuss
Loading...Carbatuss Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Sympathomimetic amines should be used with caution in patients with hypertension, ischemic heart disease, diabetes mellitus, increased intraocular pressure, hyperthyroidism, or prostatic hypertrophy. Sympathomimetics may produce central nervous system stimulation with convulsions or cardiovascular collapse with accompanying hypotension.
DO NOT EXCEED RECOMMENDED DOSAGE.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For temporary relief of nonproductive cough accompanying respiratory tract congestion associated with the common cold, influenza, sinusitis, and bronchitis.
History
There is currently no drug history available for this drug.
Other Information
Revised Formula
NDC 58809-536-01
CARBATUSS is an alcohol-free, red liquid for oral administration having a spearmint odor and flavor.
Each teaspoonful (5 mL) contains:
Carbetapentane Citrate..........................20 mg
Phenylephrine Hydrochloride..................10 mg
Guaifenesin........................................100 mg
Sources
Carbatuss Manufacturers
-
Gm Pharmaceuticals, Inc.
![Carbatuss (Carbetapentane Citrate, Phenylephrine Hydrochloride, Guaifenesin) Liquid [Gm Pharmaceuticals, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Carbatuss | Gm Pharmaceuticals, Inc.
CARBATUSS is administered orally as follows: Adults: 1-2 teaspoonfuls every 4-6 hours or as directed by a physician. Children 6-12 Years: 1 teaspoonful every 4-6 hours or as directed by a physician.
Login To Your Free Account